论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Yuan Z, Yu M, Chen Y
Received 15 July 2018
Accepted for publication 29 November 2018
Published 20 December 2018 Volume 2019:12 Pages 113—117
DOI https://doi.org/10.2147/OTT.S180309
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Dr Sanjay Singh
Abstract: Ovarian
anaplastic ependymoma is a rare gynecologic malignancy. Owing to its rarity,
treatment is challenging. Unilateral ovarian ependymoma was found during
laparoscopy in a 19-year-old woman. After cytoreductive surgery, three cycles
of bleomycin, etoposide, and cisplatin were administered. Four years after
chemotherapy, the patient experienced relapse. After the secondary cytoreductive
surgery, no further treatment was performed. She is in good condition, ~19
months after secondary cytoreductive surgery using hormone-replacement therapy
without chemotherapy. Some cases of ovarian ependymoma can be treated with
surgery alone without chemotherapy and the outcome has been satisfying.
Choosing treatment based on malignant ovarian germ cell tumors may be not
optimal. Therefore, we suggest individualized treatment for ovarian ependymoma.
Keywords: ovarian
ependymoma, contralateral ovary, chemotherapy, hormone-based treatment
